现实世界的证据用于为罕见疾病治疗的覆盖范围的确定
Victoria W Dayer1, Michael F Drummond2, Omar Dabbous3
1CHOICE Institute, School of Pharmacy, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA. vwinslow@uw.edu.
Orphanet journal of rare diseases
|February 7, 2024
概括
现实世界的证据 (RWE) 帮助卫生技术评估 (HTA) 治疗罕见疾病,但面临着重大的方法挑战. 解决这些问题对于明智的HTA决策和有效的市场准入至关重要.
科学领域:
- 医疗技术评估 (HTA) 是指对医疗技术进行评估.
- 现实世界的证据 (RWE)
- 罕见疾病治疗方法 罕见疾病治疗方法
背景情况:
- 药品的卫生技术评估 (HTA) 是复杂且不断发展的,特别是通过加速途径批准的罕见疾病治疗.
- 对于罕见病药物的加速批准计划,在进入市场时,会造成临床证据和预算影响的不确定性.
- 现实世界证据 (RWE) 建议支持罕见病治疗的HTA决策,包括通过早期覆盖与证据开发.
研究的目的:
- 描述开发和利用前性和追溯性RWE用于有关罕见疾病治疗的HTA决策的方法学挑战.
- 专注于研究设计和分析的关键要素,以在罕见疾病中产生RWE.
主要方法:
- 检查HTA前性和追溯性RWE开发中的方法挑战.
- 专注于关键的研究设计和分析组件:患者选择,混调整,偏差控制,结果选择和数据质量监测.
- 在罕见疾病的背景下,探索RWE所面临的挑战.
主要成果:
- 在收集和使用RWE用于HTA方面存在重大方法挑战,特别是在罕见疾病方面.
- 确定的主要挑战包括患者招募,混和偏差调整,结果选择和数据质量保证.
- 这篇论文概述了与罕见疾病背景下RWE的研究设计和分析方法相关的具体问题.
结论:
- 解决RWE的方法挑战对于在罕见疾病中做出强有力的HTA决策至关重要.
- 预计RWE在覆盖范围和定价方面的作用将增加.
- 研究人员,制造商,HTA机构和支付人必须在采用RWE决策时遵守严格的科学原则.
相关概念视频
Hazard Ratio
124
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
124
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K


